Jan Pippel

Jan Pippel

Auto-generated profile, based on publicly available information

Jan Pippel

Structure and Function of Proteins, Helmholtz Centre for Infection Research, Braunschweig, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Structure
Verified
Journal Article
Closed access
KKKaren Knapp
Karen Knapp
MZMatthias Zebisch
Matthias Zebisch
JPJan Pippel
Jan Pippel
AEAli El-Tayeb
Ali El-Tayeb
CMChrista Müller
Christa Müller
NSNorbert Sträter
Norbert Sträter

30 July 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SBSanjay Bhattarai
Sanjay Bhattarai
MFMarianne Freundlieb
Marianne Freundlieb
JPJan Pippel
Jan Pippel
AMAnne Meyer
Anne Meyer
AAAliaa Abdelrahman
Aliaa Abdelrahman
CMChrista Müller
Christa Müller

11 February 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SBSanjay Bhattarai
Sanjay Bhattarai
JPJan Pippel
Jan Pippel
ESEmma Rose Scaletti
Emma Rose Scaletti
RIRiham Idris
Riham Idris
MFMarianne Freundlieb
Marianne Freundlieb
NSNorbert Sträter
Norbert Sträter

31 July 2019 in Advanced Therapeutics
Verified
Journal Article
Open access
PDF file
SBSanjay Bhattarai
Sanjay Bhattarai
JPJan Pippel
Jan Pippel
AMAnne Meyer
Anne Meyer
MFMarianne Freundlieb
Marianne Freundlieb
CSConstanze Schmies
Constanze Schmies
CMChrista Müller
Christa Müller
Ecto‐5′‐nucleotidase (CD73, EC 3.1.3.5) catalyzes the extracellular hydrolysis of AMP yielding adenosine, which induces immunosuppression, angiogenesis, metastasis, and proliferation of cancer cells. CD73 inhibition is therefore proposed as a novel strategy for cancer (immuno)therapy, and CD73 antibodies are currently undergoing clinical trials. Despite considerable efforts, the development of small molecule CD73 inhibitors has met with limited success. To develop a suitable drug candidate, a high resolution (2.05 Å) co‐crystal structure of the CD73 inhibitor PSB‐12379, a nucleotide analogue, in complex with human CD73 is determined. This allows the rational design and development of a novel inhibitor (PSB‐12489) with subnanomolar inhibitory potency toward human and rat CD73, high selectivity, as well as high metabolic stability. A co‐crystal structure of PSB‐12489 with CD73 (1.85 Å) reveals the interactions responsible for increased potency. PSB‐12489 is the most potent CD73 inhibitor to date representing a powerful tool compound and novel lead structure.

27 July 2018
Verified
Book Chapter
Open access
PDF file
JWJuliane Weiner
Juliane Weiner
KZKonstanze Zieger
Konstanze Zieger
JPJan Pippel
Jan Pippel
JHJohn Heiker
John Heiker
Visceral adipose tissue-derived serine protease inhibitor (vaspin) or SERPINA12 according to the serpin nomenclature was identified together with other genes and gene products that were specifically expressed or overexpressed in the intra-abdominal or visceral adipose tissue (AT) of the Otsuka Long-Evans Tokushima fatty rat. These rats spontaneously develop visceral obesity, insulin resistance, hyperinsulinemia and -glycemia, as well as hypertension and thus represent a well suited animal model of obesity and related metabolic disorders such as type 2 diabetes. The follow-up study reporting the cloning, expression and functional characterization of vaspin suggested the great and promising potential of this molecule to counteract obesity induced insulin resistance and inflammation and has since initiated over 300 publications, clinical and experimental, that have contributed to uncover the multifaceted functions and molecular mechanisms of vaspin action not only in the adipose, but in many different cells, tissues and organs. This review will give an update on mechanistic and structural aspects of vaspin with a focus on its serpin function, the physiology and regulation of vaspin expression, and will summarize the latest on vaspin function in various tissues such as the different adipose tissue depots as well as the vasculature, skin, bone and the brain.

1 October 2017 in Cell Chemical Biology
Verified
Journal Article
Closed access
ATAlexander von Tesmar
Alexander von Tesmar
MHMichael Hoffmann
Michael Hoffmann
JPJan Pippel
Jan Pippel
AFAntoine Abou Fayad
Antoine Abou Fayad
SDStefan Dausend-Werner
Stefan Dausend-Werner
RMRolf Müller
Rolf Müller